Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Home >
The Pharmaceutical Market: Peru
Management Report
Published: January 2010
Pages: 66
Tables: For full details, please email keithw@cmsinfo.com
From: GBP 595.00 Buy Now!
Research from: Espicom
Sector: Prescription Medicines
Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
Peru is often overlooked when discussing the rapid-growth economies of South America. While it has neither the size nor the wealth of Brazil or Argentina, the country has a population which will exceed 30 million by 2011, and has recorded strong economic growth in recent years. According to the Economist Intelligence Unit (EIU), GDP growth is expected to increase by 3.0% in real terms in 2010, following a nearly flat growth in 2009. GDP per capita wealth has risen, especially around Lima, leading to a sizeable urban population which demands improved healthcare and has the ability to pay for it. This economic environment is expected to encourage drug consumption.
The pharmaceutical market is expected to increase by a high one digit CAGR in dollar terms between 2010 and 2015. Production is mainly undertaken by local producers of branded generics or generics under ICD. Leading domestic producers include Farmindustria, Infarmasa Corporation (Magma and Sanitas), Medifarma and Medco Corporation (Cofana and Marfan). Peru liberalised the drug pricing system in the 1990s, resulting in high price increases, particularly of original drugs. To control prices, the Ministry of Health (MINSA) has created an ‘observatory of drug prices’ (OBSERMED). Domestically produced medicines represent 70.0% of the total.
The Trade Promotion Agreement (TPA) signed with the USA, effective from February 2009, should result in further intellectual property compliance by the pharmaceutical industry, a more competitive market and more widespread generics use by the government. Further intellectual property enforcements are expected to result in increasing pharmaceutical expenditure between 2011 and 2017, according to studies undertaken by the National Patent Office (INDECOPI) and the Ministry of Health (MINSA).
Highly detailed report content
MARKET OUTLOOK
Key national data projections
Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development
Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property
Pharmaceutical distribution
Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel
The pharmaceutical market is expected to increase by a high one digit CAGR in dollar terms between 2010 and 2015. Production is mainly undertaken by local producers of branded generics or generics under ICD. Leading domestic producers include Farmindustria, Infarmasa Corporation (Magma and Sanitas), Medifarma and Medco Corporation (Cofana and Marfan). Peru liberalised the drug pricing system in the 1990s, resulting in high price increases, particularly of original drugs. To control prices, the Ministry of Health (MINSA) has created an ‘observatory of drug prices’ (OBSERMED). Domestically produced medicines represent 70.0% of the total.
The Trade Promotion Agreement (TPA) signed with the USA, effective from February 2009, should result in further intellectual property compliance by the pharmaceutical industry, a more competitive market and more widespread generics use by the government. Further intellectual property enforcements are expected to result in increasing pharmaceutical expenditure between 2011 and 2017, according to studies undertaken by the National Patent Office (INDECOPI) and the Ministry of Health (MINSA).
Highly detailed report content
MARKET OUTLOOK
Key national data projections
Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development
Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property
Pharmaceutical distribution
Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel